The potential value of MRI in external-beam radiotherapy for cervical cancer.
Livsey, Jacqueline E
Barraclough, Lisa H
van Herk, Marcel
AffiliationDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M20 4BX,
MetadataShow full item record
AbstractThe reference standard treatment for cervical cancer is concurrent chemoradiotherapy followed by magnetic resonance imaging (MRI)-guided brachytherapy. Improvements in brachytherapy have increased local control rates, but late toxicity remains high with rates of 11% grade ≥3. The primary clinical target volume (CTV) for external-beam radiotherapy includes the cervix and uterus, which can show significant inter-fraction motion. This means that generous margins are required to cover the primary CTV, increasing the radiation dose to organs at risk and, therefore, toxicity. A number of image-guided radiotherapy techniques (IGRT) have been developed, but motion can be random and difficult to predict prior to treatment. In light of the development of integrated MRI linear accelerators, this review discusses the potential value of MRI in external-beam radiotherapy. Current solutions for managing pelvic organ motion are reviewed, including the potential for online adaptive radiotherapy. The impacts of the use of MRI in tumour delineation and in the delivery of stereotactic ablative body radiotherapy (SABR) are highlighted. The potential role and challenges of using multi parametric MRI to guide radiotherapy are also discussed.
CitationThe potential value of MRI in external-beam radiotherapy for cervical cancer. 2018, 30(11): 737-750 Clin Oncol (R Coll Radiol)
- A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer.
- Authors: Jadon R, Pembroke CA, Hanna CL, Palaniappan N, Evans M, Cleves AE, Staffurth J
- Issue date: 2014 Apr
- 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
- Authors: Mazeron R, Petit C, Rivin E, Limkin E, Dumas I, Maroun P, Annede P, Martinetti F, Seisen T, Lefkopoulos D, Chargari C, Haie-Meder C
- Issue date: 2016 Mar
- Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
- Authors: Ribeiro I, Janssen H, De Brabandere M, Nulens A, De Bal D, Vergote I, Van Limbergen E
- Issue date: 2016 Sep
- Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
- Authors: Schuetz M, Schmid MP, Pötter R, Kommata S, Georg D, Lukic D, Dudczak R, Kletter K, Dimopoulos J, Karanikas G, Bachtiary B
- Issue date: 2010 Oct
- Integration of MRI target delineation into rapid workflow cervical cancer brachytherapy: Impact on clinical outcomes.
- Authors: Dutta SW, Trifiletti DM, Pugh KJ, Romano KD, Libby B, Showalter TN
- Issue date: 2018 Oct